Advocacy

Newspaper Reports Questionable Involvement of Schering-Plough in Hepatitis C Coalitions

Published in Medical Letter on the CDC and FDA, October 8th, 2000

In what appears to be a bold marketing ploy, drugmaker Schering-Plough reportedly created a number of "grass-roots" hepatitis C coalitions in the U.S. for the purposes of selling its antiviral drug, Rebetron, while ostensibly educating the public about the dangers of the hepatitis C virus, says the Washington Post newspaper.

And now the U.S. Food and Drug Administration is taking a closer look at the company's tactics.

Washington Post staff writer Robert O'Harrow, Jr., covered the story in two articles. In the September 12, 2000, edition of the newspaper, O'Harrow revealed that since 1997, hundreds of volunteers have joined hepatitis C groups in 11...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2000-10-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry